Skip to Content

Oncology Optimized Limited Distribution Table

The NCODA-preferred model for oncology care delivery, Oncology Optimized Limited Distribution (OOLD), excludes PBM-affiliated mail-order pharmacies while allowing MIPs and non-PBM mail-order pharmacies to dispense. This approach promotes coordinated, in-practice care and ensures timely, patient-centered treatment. NCODA remains dedicated to ongoing education and advocacy to expand access to this model wherever possible.

Learn More About OOLD

The NCODA OOLD Search Table is designed to help oncology teams navigate the complexities of oral anticancer medication distribution. It provides comprehensive information on a wide range of therapies, including brand and generic names, associated disease states, manufacturers, and specific distribution models. By supporting medically integrated dispensing practices, the OOLD Search Table promotes improved coordination, adherence, and patient outcomes in oncology care.

 *The MIP must meet additional requirements to dispense. For many of the products that are listed as “Generically Available” the brand name and manufacturer are listed for reference only. 

NCODA Distribution Model Definitions

NCODA defines four primary models within the limited distribution landscape.

Applies to medications with highly restricted networks, such as those requiring REMS or manufacturer-designated controls. These models typically offer little to no flexibility in dispensing, often excluding MIPs altogether. This includes models with no MIP Access. 

Represents the NCODA preferred model, where PBM affiliated mail order pharmacies are excluded, and MIPs and non-PBM affiliated pharmacies can dispense. This model enables coordinated, in-practice care and supports timely, patient-centered treatment. NCODA is committed to continued education and advocacy to expand access to this approach wherever possible. 

Includes one or two PBM-affiliated mail order pharmacies which include Optum, CVS Caremark, or Express Scripts. While not preferred, it is important to recognize manufacturers that are attempting to promote MIPs and limit access to PBM owned pharmacies. 

*This distribution networks limit MIP involvement and introduce barriers to timely access and coordinated care, often through restrictive contracting or payer-driven steerage. 

Medications widely available through retail, hospital and mail order pharmacies without restrictions. Includes Optum, CVS Caremark, and Express Scripts PBM-affiliated mail order pharmacies. 

*These distribution networks limit MIP involvement and introduce barriers to timely access and coordinated care, often through restrictive contracting or payer-driven steerage. 

MIP search tool helps to quickly identify Medically Integrated Pharmacies (MIPs) located within oncology practices and alternative ordering options.These resource supports medically integrated dispensing practices, aiming to improve coordination, adherence, and outcomes in oncology care.

Learn More